Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Mar 1;167(3):954-73.
doi: 10.1084/jem.167.3.954.

Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies

Affiliations

Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies

N C Chien et al. J Exp Med. .

Erratum in

  • J Exp Med 1990 Aug 1;172(2):669

Abstract

The genetic mechanism responsible for the somatic diversification of two mAbs was determined. The two PC-binding hybridomas were representative of events early and late in the immune response. The P28 cell line that produces an IgM antibody and thus represents events early in the immune response, was found to have 3 bp changes in its heavy chain variable (VH) region, with some changes in antibody affinity or specificity. The RP93 cell line that produces an IgG2a antibody and thus represents later events in the immune response, was found to have 9 bp changes in its VH region resulting in decreased affinity for PC and altered specificity. Oligonucleotides specific for linked base changes in the second hypervariable regions of both of these antibodies were used to look for previously undescribed V regions or other donor sequences that could have been responsible for these base changes. Since no donor sequences were found, we have concluded that somatic point mutation rather than gene conversion, V region replacement or the expression of an unidentified germline VH region gene is truly responsible for at least some of the somatic diversification of these antibodies.

PubMed Disclaimer

References

    1. Nature. 1986 Aug 28-Sep 3;322(6082):843-6 - PubMed
    1. Nature. 1986 Aug 28-Sep 3;322(6082):840-2 - PubMed
    1. J Exp Med. 1986 Dec 1;164(6):2107-12 - PubMed
    1. Cell. 1987 Feb 13;48(3):379-88 - PubMed
    1. J Immunol. 1987 Mar 1;138(5):1607-12 - PubMed

Publication types

MeSH terms

Associated data